PLK1 is overexpressed in various human cancers, including melanoma [36], prostate cancer [37], colorectal cancer [38], hepatocellular carcinoma [39], and breast cancer [40], and its expression is associated with enhanced cell proliferation and poor prognosis in patients with cancer [41]. Here, PLK1 is linked to prostate carcinoma.